Brazil’s Internet Legal Framework Regulation And Draft Bill For Privacy Law Public Consultation

Flavia Rebello

On 28 January 2015, the Brazilian Ministry of Justice launched public consultations involving two key pieces of legislation, namely: the decree that will regulate the Marco Civil da Internet or the Brazilian Civil Rights Framework for the Internet (the “Internet Legal Framework”); and the Draft Bill for the Protection of Personal Data (“Draft Bill”). A consultation period is being conducted in relation to these two laws via online platforms set up by the government.

The Legal Implications Of Medicinal Marijuana As A Geographical Indication For Jamaica

Cannabis_sativa_Koehler_drawing

Although there are ongoing negotiations to revise the Lisbon Agreement for the international recognition of GIs, there is currently no uniform reciprocal legal recognition for non-wine and spirit GIs in international jurisdictions. Jamaica’s Cannabis (hereafter marijuana), is identified by its government as one of the country’s products which is domestically GI registrable, writes Marsha Cadogan.

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Ellen 't Hoen

Ellen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.

It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.

US Congress Reconsiders Anti-Patent Troll Law

US_Capitol_dome

It happened again on 5 February. The powerful chair of the House Judiciary Committee, Rep. Bob Goodlatte introduced the Innovation Act for a second time. This bill, aimed at hurting patent trolls by making a plethora of changes in US patent law, easily passed the House of Representatives last term. It subsequently bogged down in a Democrat-controlled Senate. However, now that the GOP controls both wings of Congress, many observers predict the bill will have soon become law. Other experts aren’t so sure, noting that the Innovation Act is drawing some powerful opposition – and not just from patent trolls.

Copyright Policy And The Right To Science And Culture

OHCHR-logo

Reposted from Afro-IP and infojustice.org: A report entitled ‘Copyright policy and the right to science and culture’ authored by the UN Special Rapporteur in the field of cultural rights, Farida Shaheed, has been released, writes Prof. Carolyn Ncube.

ANEPI IP News: Tres Cerveceros Y Una Marca (Three Brewers And A Brand)

three beers

Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]

Year Ahead: Key IP-Related Issues, Dates At The WTO In 2015

WTO-logo_lite_en-200x200

This year is shaping up to be a busy one for the World Trade Organization, and intellectual property issues are among those coming up.

US Challenges For Biotech In 2015 – An Interview With BIO’s Hans Sauer

Hans Sauer

The biotechnology industry is closely watching developments in the United States that could impact the industry in 2015. These include the regulatory framework for biosimilars, possible patent legislation, post-grant review procedure, and the consequences of the recent Supreme Court ruling banning the patenting of human genes. Hans Sauer, Deputy General Counsel for Intellectual Property at the Biotechnology Industry Organization (BIO), recently spoke with Intellectual Property Watch’s Catherine Saez. Sauer was asked to lay out the main developments to watch in the coming year.

South Africa Supreme Court Of Appeal Losing Its Shape

CIP-logo-300x300

South Africa’s Supreme Court of Appeal has been blessed for the past few decades by having in its ranks judges who have experience and expertise in the field of Intellectual Property Law, writes law professor Owen Dean. With the recent retirement of Louis Harms, the bench at the Supreme Court of Appeal has been denuded of judges who can be regarded as IP experts. The paucity of IP experience on the bench is regrettably beginning to show.

In recent times the Supreme Court of Appeal has given three IP judgments in trade mark cases which, it is respectfully submitted, have been wrongly decided and are not in harmony with the principles of trade mark law and practice, Dean argues.

Unlimited Potential: The Innovation Renaissance Is Now

GIPC index cover

By Patrick Kilbride At no other time in history has humanity enjoyed such a boundless period of innovation.  The human experience is literally changing day-to-day as new medicines and new technologies create solutions to seemingly insurmountable global challenges such as poverty, hunger, disease, and climate change.  This 21st century innovation renaissance could not be more […]